News | August 12, 2014

Survival Increases With Clinical Team Debriefing After In-hospital Cardiac Arrest

Lessons learned prepare team for future cases and increase chance of favorable neurologic outcome

August 12, 2014 — A new study found that staff members who joined structured team debriefings after emergency care for children suffering in-hospital cardiac arrests improved their CPR performance and substantially increased the rates of patients surviving with favorable neurological outcomes.

The study team at The Children's Hospital of Philadelphia (CHOP) said their research suggests that including all members of the intensive care unit (ICU) team, not just those immediately involved in the cardiac arrests, broadens learning and may improve compliance with standardized national guidelines for performing CPR. "Bringing together all members of the multidisciplinary team for a post-event debrief better prepares everyone who could come in future contact with a patient in sudden cardiac arrest," said lead author Heather Wolfe, M.D., a critical care physician at The Children's Hospital of Philadelphia.

More than 200,000 cardiac arrests occur every year in U.S. hospitals. And while survival outcomes have improved over the last 10 years, still more than 60 percent of these patients will not make it out of the hospital alive. This fact highlights how important it will be to disseminate the team's successful findings.

The current study appears in a recent issue of Critical Care Medicine.

The researchers performed a single-center prospective study of children who received chest compressions in the ICU at CHOP between December 2008 and June 2012, encompassing 120 CPR events. The study team compared a historical control group, up to June 2010, with an intervention group of patients receiving CPR between December 2010 and June 2012, following the implementation of the post-arrest debriefing program. Patient survival with favorable neurologic outcome increased to 50 percent among the intervention group, compared to 29 percent during the pre-intervention period.

"The team debriefings were associated with a near-doubling of good neurological survival for children who suffer a cardiac arrest in our ICU," said Wolfe, who added, "Our unique, interdisciplinary debriefing program resulted in improvements of CPR technique to levels of American Heart Assn. (AHA) Guideline compliance previously not thought possible — this was truly a stellar achievement."

At The Children's Hospital of Philadelphia, all ICU physicians, respiratory therapists and nurses are certified in pediatric advanced life support and/or advanced cardiovascular life support and participate in frequent mock code and rolling refresher CPR training.

"This study demonstrates how doctors, nurses, and other healthcare providers can come together to improve in-hospital care and save lives," said Robert Sutton, M.D., M.S.C.E., chair of the hospital's Resuscitation Committee and senior author on the project.   

"This is the first study in children showing that pre-training with simulation and debriefing teams on how we can do it better improves survival.  It also highlights what a unique program we have here for cardiac arrest patients from prevention, care during arrest, and post-arrest care," said Robert Berg, M.D., chief of critical care medicine at The Children's Hospital of Philadelphia.

For more information: www.chop.edu

Related Content

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

News | Cardiovascular Clinical Studies | July 22, 2020
July 22, 2020 — Eating chocolate at least once a week is linked with a reduced risk of heart disease, according to re
The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

News | Cardiovascular Clinical Studies | January 20, 2020
January 20, 2020 — Scientists at Los Alamos and international partners have created the first 3-D images of a special
Top Cardiology New in 2019 From the European Society of Cardioloigy (ESC)
News | Cardiovascular Clinical Studies | December 23, 2019
Environmental and lifestyle issues were popular this year, with pick up from both...
News | Cardiovascular Clinical Studies | November 26, 2019
November 26, 2019 — The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare have sele
FDA Issues Final Guidance on Live Case Presentations During IDE Clinical Trials
News | Cardiovascular Clinical Studies | July 10, 2019
The U.S. Food and Drug Administration (FDA) issued the final guidance “Live Case Presentations During Investigational...
Veradigm Partners With American College of Cardiology on Next-generation Research Registries
News | Cardiovascular Clinical Studies | July 03, 2019
The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to power the next...
New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp